Long-Term Assets: The sum of all assets classified as non-current.
PDS Biotechnology Corporation (PDSB) had Long-Term Assets of $2.24M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.56M |
|
-- |
|
-- |
|
$6.67M |
|
$-6.67M |
|
$-0.89M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-6.67M |
|
$-6.19M |
|
46.38M |
|
46.38M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$28.25M |
|
$0.12M |
|
|
Long-Term Assets |
$2.24M |
$30.49M |
|
$9.48M |
|
$11.76M |
|
$11.76M |
|
$21.24M |
|
$9.25M |
|
$9.25M |
|
$9.25M |
|
54.88M |
|
| Cash Flow Statement Financials | |
$-27.75M |
|
-- |
|
$12.77M |
|
$41.69M |
|
$26.71M |
|
$-14.98M |
|
$4.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.98 |
|
-- |
|
-- |
|
0.56 |
|
1.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-81.75% |
|
-81.75% |
|
-24.80% |
|
-36.00% |
|
$0.17 |
|
$-0.60 |
|
$-0.60 |
|